Zefen Xiao

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 16

Top Venues

BMC cancer

Therapeutic advances in medical oncology

Journal of oncology

Thoracic cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Chen Li, Xiao Chang, Qifeng Wang, Qingsong Pang, Zefen Xiao, Wencheng Zhang, Zhiyong Yuan
Two distinct age-prognosis patterns in patients with esophageal cancer undergoing surgical and radiotherapy treatments: a combined analysis of 3JECROG and SEER databases. Therapeutic advances in medical oncology 16 (2024)
Chen Li, Xiao Chang, Qifeng Wang, Qingsong Pang, Zefen Xiao, Wencheng Zhang, Zhiyong Yuan
Two distinct age-prognosis patterns in patients with esophageal cancer undergoing surgical and radiotherapy treatments: a combined analysis of 3JECROG and SEER databases. Therapeutic advances in medical oncology 16 (2024)
Weiming Han, Chen Li, Wei Deng, Wenjie Ni, Xiao Chang, Linrui Gao, Shijia Wang, Xin Wang, Zefen Xiao
Radiation Dose-Effect Relation in Patients with Esophageal Squamous Cell Carcinoma: A National Cancer Center Data and Literature-Based Analysis. Journal of oncology 2022 (2022)
Shijia Wang, Baoyan Ji, Chen Li, Weiming Han, Xin Wang, Zongmei Zhou, Dongfu Chen, Qinfu Feng, Jun Liang, Jima Lv, Nan Bi, Lei Deng, Wenqing Wang, Tao Zhang, Zefen Xiao
Factors affecting the completion of concurrent chemotherapy and impact of non-completion on survival in locally advanced esophageal squamous cell carcinoma. Esophagus : official journal of the Japan Esophageal Society 19 (4) (2022)
Weiming Han, Lan Wang, Chen Li, Junqiang Chen, Wencheng Zhang, Xin Wang, Qingsong Pang, Yidian Zhao, Xinchen Sun, Kaixian Zhang, Gaofeng Li, Ling Li, Xueying Qiao, Miaoling Liu, Yadi Wang, Lei Deng, Wenqing Wang, Nan Bi, Tao Zhang, Wei Deng, Wenjie Ni, Xiao Chang, Zongmei Zhou, Jun Liang, Qinfu Feng, Lvhua Wang, Dongfu Chen, Jima Lv, Shuchai Zhu, Chun Han, Zefen Xiao
Progression-free survival as surrogate endpoint of overall survival in esophageal squamous cell carcinoma: a real-world data and literature-based analysis. Therapeutic advances in medical oncology 14 (2022)
Lin-Rui Gao, Chen Li, Weiming Han, Wenjie Ni, Wei Deng, Lijun Tan, Zongmei Zhou, Dongfu Chen, Qinfu Feng, Jun Liang, Jima Lv, Wenqing Wang, Wenyang Liu, Lei Deng, Xin Wang, Tao Zhang, Jianyang Wang, Yirui Zhai, Nan Bi, Lvhua Wang, Zhouguang Hui, Ye-Xiong Li, Zefen Xiao
Survival benefit of surgery in patients with clinical T4 esophageal cancer who achieved complete or partial response after neoadjuvant chemoradiotherapy or radiotherapy. Therapeutic advances in medical oncology 14 (2022)
Xiao Chang, Wei Deng, Xin Wang, Zongmei Zhou, Jun Yang, Wenling Guo, Miaoling Liu, Xiaolu Qi, Ling Li, Kaixian Zhang, Min Zhang, Yonggang Shi, Ke Liu, Yidian Zhao, Huitao Wang, Zhilong Yu, Jihong Zhang, Lihua Wang, Xueying Qiao, Chun Han, Shuchai Zhu, Ruohui Zhang, Junqiang Chen, Cairong Hu, Fuquan Zhang, Xiaorong Hou, Qingsong Pang, Wencheng Zhang, Gaofeng Li, Hailei Lin, Xinchen Sun, Xiaolin Ge, Caihong Li, Hong Ge, Dingjie Li, Yadi Wang, Na Lu, Xianshu Gao, Shangbin Qin, Yuan Tian, Zefen Xiao
Interobserver variability in target volume delineation in definitive radiotherapy for thoracic esophageal cancer: a multi-center study from China. Radiation oncology (London, England) 16 (1) (2021)
Xiao Chang, Wei Deng, Wenjie Ni, Chen Li, Weiming Han, Lin-Rui Gao, Shijia Wang, Zongmei Zhou, Dongfu Chen, Qinfu Feng, Nan Bi, Shugeng Gao, Yu Lin, Junqiang Chen, Zefen Xiao
Comparison of Two Major Staging Systems in Predicting Survival and Recommendation of Postoperative Radiotherapy Based on the 11th Japanese Classification for Esophageal Carcinoma After Curative Resection: A Propensity Score-Matched Analysis. Annals of surgical oncology 28 (12) (2021)
Xiao Chang, Junqiang Chen, Wencheng Zhang, Jinsong Yang, Shufei Yu, Wei Deng, Wenjie Ni, Zongmei Zhou, Dongfu Chen, Qinfu Feng, Jima Lv, Jun Liang, Zhouguang Hui, Lvhua Wang, Yu Lin, Xiaohui Chen, Qi Xue, Yousheng Mao, Yushun Gao, Dali Wang, Feiyue Feng, Shugeng Gao, Jie He, Zefen Xiao
Recurrence risk stratification based on a competing-risks nomogram to identify patients with esophageal cancer who may benefit from postoperative radiotherapy. Therapeutic advances in medical oncology 13 (2021)
Yufan Yang, Tao Zhang, Zongmei Zhou, Jun Liang, Dongfu Chen, Qin-Fu Feng, Zefen Xiao, Zhouguang Hui, Jima Lv, Lei Deng, Xin Wang, Wenqing Wang, Jianyang Wang, Wenyang Liu, Yirui Zhai, Jie Wang, Nan Bi, Luhua Wang
Development and validation of a prediction model using molecular marker for long-term survival in unresectable stage III non-small cell lung cancer treated with chemoradiotherapy. Thoracic cancer 13 (3) (2021)
Wenjie Ni, Jinsong Yang, Wei Deng, Zefen Xiao, Zongmei Zhou, Hongxing Zhang, Dongfu Chen, Qinfu Feng, Jun Liang, Jima Lv, Xiaozhen Wang, Xin Wang, Tao Zhang, Nan Bi, Lei Deng, Wenqing Wang
Patterns of recurrence after surgery and efficacy of salvage therapy after recurrence in patients with thoracic esophageal squamous cell carcinoma. BMC cancer 20 (1) (2020)
Xiao Chang, Lei Deng, Wenjie Ni, Chen Li, Weiming Han, Lin-Rui Gao, Shijia Wang, Zongmei Zhou, Dongfu Chen, Qinfu Feng, Jun Liang, Nan Bi, Jima Lv, Shugeng Gao, Yousheng Mao, Qi Xue, Zefen Xiao
Salvage chemoradiation therapy for recurrence after radical surgery or palliative surgery in esophageal cancer patients: a prospective, multicenter clinical trial protocol. BMC cancer 20 (1) (2020)
Lin-Rui Gao, Xin Wang, Weiming Han, Wei Deng, Chen Li, Xiaomin Wang, Yidian Zhao, Wenjie Ni, Xiao Chang, Zongmei Zhou, Lei Deng, Wenqing Wang, Wenyang Liu, Jun Liang, Tao Zhang, Nan Bi, Jianyang Wang, Yirui Zhai, Qinfu Feng, Jima Lv, Ling Li, Zefen Xiao
A multicenter prospective phase III clinical randomized study of simultaneous integrated boost intensity-modulated radiotherapy with or without concurrent chemotherapy in patients with esophageal cancer: 3JECROG P-02 study protocol. BMC cancer 20 (1) (2020)
Wenjie Ni, Shufei Yu, Wencheng Zhang, Zefen Xiao, Zongmei Zhou, Dongfu Chen, Qinfu Feng, Jun Liang, Jima Lv, Shugeng Gao, Yousheng Mao, Qi Xue, Kelin Sun, Xiangyang Liu, Dekang Fang, Jian Li, Dali Wang
A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma. BMC cancer 20 (1) (2020)
Chen Li, Xiaomin Wang, Xin Wang, Chun Han, Ping Wang, Qingsong Pang, Junqiang Chen, Xinchen Sun, Lan Wang, Wencheng Zhang, Yu Lin, Xiaolin Ge, Zongmei Zhou, Wenjie Ni, Xiao Chang, Jun Liang, Lei Deng, Wenqing Wang, Yidian Zhao, Zefen Xiao
A multicenter phase III study comparing Simultaneous Integrated Boost (SIB) radiotherapy concurrent and consolidated with S-1 versus SIB alone in elderly patients with esophageal and esophagogastric cancer - the 3JECROG P-01 study protocol. BMC cancer 19 (1) (2019)
Chen Li, Xiaomin Wang, Xin Wang, Chun Han, Ping Wang, Qingsong Pang, Junqiang Chen, Xinchen Sun, Lan Wang, Wencheng Zhang, Yu Lin, Xiaolin Ge, Zongmei Zhou, Wenjie Ni, Xiao Chang, Jun Liang, Lei Deng, Wenqing Wang, Yidian Zhao, Zefen Xiao
Correction to: A multicenter phase III study comparing Simultaneous Integrated Boost (SIB) radiotherapy concurrent and consolidated with S-1 versus SIB alone in elderly patients with esophageal and esophagogastric cancer - the 3JECROG P-01 study protocol. BMC cancer 19 (1) (2019)

Zefen Xiao.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Zefen Xiao